A THERAPEUTIC TRIAL OF MILACEMIDE IN MYOCLONUS AND THE STIFF-PERSON SYNDROME

被引:10
作者
BROWN, P [1 ]
THOMPSON, PD [1 ]
ROTHWELL, JC [1 ]
DAY, BL [1 ]
MARSDEN, CD [1 ]
机构
[1] INST NEUROL,MRC,HUMAN MOVEMENT & BALANCE UNIT,LONDON WC1N 3BG,ENGLAND
关键词
MYOCLONUS; STIFF-PERSON SYNDROME; MILACEMIDE;
D O I
10.1002/mds.870060114
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred in the 10 patients.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 18 条
[1]  
Aprison MH., Glycine as a neurotransmitter, Psychopharmacology, a generation of progress, pp. 333-346, (1978)
[2]  
Blume HW, Pittman QJ, Renaud LP., Sensitivity of identified medial thalamic neurons to GABA, glycine and related amino acids. Influence of bicuculline, picrotoxin and strychnine on synaptic inhibition, Brain Research, 209, pp. 145-158, (1981)
[3]  
Semba T, Kano M., Cats with local tetanus rigidity, Science, 164, pp. 571-572, (1969)
[4]  
Stern P, Hadzcarovic S., Effect of glycine on experimental hindlimb rigidity in rats, Life Sci, 9, pp. 955-959, (1970)
[5]  
Spehlmann R, Norcross K., Stiff‐man syndrome, Clinical Neuropharmacology, 4, pp. 109-121, (1979)
[6]  
Chung E, Van Woert MH., DDT myoclonus: sites and mechanism of action, Exp Neurol, 85, pp. 273-282, (1984)
[7]  
Chung E, Yocca F, Van Woert MH., Urea‐induced myoclonus: medullary glycine antagonism as mechanism of action, Life Sci, 36, pp. 1051-1058, (1985)
[8]  
Truong DD, De Y, Ebenes JG, Pezzoli G, Jackson-Lewis V, Fahn S., Glycine involvement in DDT‐induced myoclonus, Movement Disorders, 2, pp. 77-87, (1987)
[9]  
Gundlach AL, Dodd PR, Grabara CSG, Et al., Deficit of spinal cord glycine/strychnine receptors in inherited myoclonus of Poll Hereford calves, Science, 241, pp. 1807-1810, (1988)
[10]  
Christophe J, Kutzner R, Nguyen-Bui ND, Damien C, Chatelain P, Gillet L., Conversion of orally administered 2‐n‐pentylaminoacetamide into glycinamide and glycine in the rat brain, Life Sci, 33, pp. 533-541, (1983)